USPTO serial 79142823
BIOSOLVE
Reviewed by CopyMark Law Group
Reg. 4805843Status 404
- Filing date
- Status date
- Registration date
- Sep 8, 2015
- Examiner
- BLAIR, JASON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOSOLVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Fraser
RENTSCH PARTNER AG Dykema Gossett PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical or pharmaceutical preparations for medical purposes, namely, pharmaceutical polymer preparations and polylactide-limus preparations, for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical or pharmaceutical preparations for medical devices, namely, coatings for medical devices and stents; chemical preparations for pharmaceutical purposes, namely, pharmaceutical polymer preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; medicines for medical purposes, namely, pharmaceutical preparations belonging to the paclitaxel family of medicines, and pharmaceutical preparations belonging to the limus family of medicines, particularly, sirolimus, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus and limus derivatives, all for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissue; pharmaceutical preparations for human use, for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; metal alloys for medical purposes; magnesium alloys for medical purposes | SECTION 71 - CANCELLED | — |
| 006 | Common metals and their alloys; raw metal for manufacturing medical devices, stents and, markers; wire of common metals; pipes of metal; alloys of common metals; metal alloys for manufacture of medical devices, stents and markers; tantalum; magnesium; magnesium alloys; magnesium alloys for use in the manufacture stents; metals in powder form; brazing rods; alloys for brazing; metal moldings building | SECTION 71 - CANCELLED | — |
| 010 | Surgical and medical apparatus and instruments, namely, vascular and cardiovascular equipment and implants; catheters, namely, catheters for balloon dilatation, catheters for percutaneous transluminal coronary angioplasty (PTCA), catheters for percutaneous transluminal angioplasty (PTA), catheters for percutaneous coronary intervention (PCI), balloons for vessel dilatation, medical guidewires, medical instruments and apparatus, particularly stents, balloon stents, self-expanding stents, balloon expandable stents, drug-eluting stents, absorbable stents, absorbable scaffolds, surgical implants comprised of artificial material | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biotronik AG
- Other trademarks owned by Biotronik AG
- Other trademarks owned by Biotronik AG
- Other trademarks in Class 005
- Other trademarks in Class 006
- Other trademarks in Class 010
- Similar marks named BIOSOLVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 26, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| May 26, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| May 26, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 30, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 14, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 14, 2022 | INPC | INVALIDATION PROCESSED | — |
| Nov 25, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 25, 2022 | C71T | CANCELLED SECTION 71 | — |
| Jun 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 8, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 12, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 17, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 23, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 23, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 8, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 2, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 7, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 23, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 22, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 22, 2015 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 23, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 3, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 3, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 3, 2015 | NPUB | NOTICE OF PUBLICATION | — |
| May 20, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 20, 2015 | ALIE | ASSIGNED TO LIE | — |
| Apr 27, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 28, 2014 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 27, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 10, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 10, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2014 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 6, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 4, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 3, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 24, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |